| Pharmaceutical active ingredients: |
| AspirinPravastatin Sodium |
| Available forms, composition and doses of Pravasa: |
| Tablets, Delayed Release; Oral; 81 mg; 10 mgTablets, Delayed Release; Oral; 81 mg; 20 mgTablets, Delayed Release; Oral; 81 mg; 40 mg |
| Pravasa medical category: |
| Human:HMG-COA reductase inhibitorsSalicylates |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C10AA53 - Pravastatin, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Paladin Laboratories |